| DSM 18315| JCM 13406| Parabacteroides johnsonii| Parabacteroides johnsonii Sakamoto et al. 2007 emend. Hahnke et al. 2016| strain M-165
Gut Microbiota: Parabacteroides johnsonii is one of the many bacterial species that inhabit the human gut. The gut microbiota plays a crucial role in various physiological functions, including digestion, nutrient metabolism, and immune system regulation.
Anti-Inflammatory Properties: Some studies suggest that Parabacteroides johnsonii may have anti-inflammatory properties. It has been associated with the modulation of the immune response in the gut and may contribute to the maintenance of intestinal homeostasis.
Metabolic Effects: Research has indicated that specific strains of Parabacteroides johnsonii may influence metabolic processes. For example, they have been studied in the context of obesity and metabolic disorders, with some evidence suggesting a potential role in metabolic regulation.
Probiotic Potential: Given its presence in the gut and its potential health-related effects, Parabacteroides johnsonii has been investigated for its probiotic potential. Probiotics are live microorganisms that, when administered in adequate amounts, can confer health benefits to the host.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab Low and High are calculated using the formula that most labs use: Mean - 2 Standard Deviation to Mean + 2 Standard Deviation
Lab | KM Low | KM Percentile Low | KM High | KM Percentile High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High |
---|---|---|---|---|---|---|---|---|---|---|---|
* | 16 | 0 %ile | 35850 | 100 %ile | 0 | 15524 | 2748.5 | 130 | 6518.4 | 0 | 4970 |
biomesight | 30 | 9.1 %ile | 859 | 91.2 %ile | 0 | 10389 | 1422.6 | 130 | 4574.7 | 0 | 670 |
thorne | 1 | 9.1 %ile | 11 | 81.8 %ile | 0 | 12 | 4.1 | 2 | 3.9 | 1 | 11 |
thryve | 1 | 0 %ile | 1942 | 90.2 %ile | 0 | 39251 | 2881.2 | 36 | 18555.9 | 7 | 501 |
ubiome | 24 | 0 %ile | 34976 | 100 %ile | 0 | 18903 | 5806.2 | 3616 | 6681.9 | 0 | 14898 |
Low Boundary | High Boundary | Low Boundary %age | High Boundary %age | Lab Samples |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 80.436 % | 0.132 % | 0.441 % | 2286.0 | 2842 |
BiomeSightRdp | 12.5 % | 1.468 % | 1.539 % | 4.0 | 32 |
bugspeak | 100 % | 0.013 % | % | 1.0 | 1 |
CerbaLab | 100 % | 0.069 % | 0.059 % | 3.0 | 3 |
CosmosId | 43.75 % | 0.077 % | 0.126 % | 14.0 | 32 |
custom | 6.78 % | 0.12 % | 0.17 % | 4.0 | 59 |
es-xenogene | 3.448 % | 0.027 % | % | 1.0 | 29 |
Medivere | 100 % | 0.093 % | 0.222 % | 7.0 | 7 |
SequentiaBiotech | 2.778 % | 0.53 % | % | 1.0 | 36 |
Thorne | 12.941 % | 0 % | 0 % | 11.0 | 85 |
Thryve | 33.261 % | 0.27 % | 1.736 % | 459.0 | 1380 |
uBiome | 13.384 % | 0.581 % | 0.668 % | 106.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.